0002040125-24-000001.txt : 20241004 0002040125-24-000001.hdr.sgml : 20241004 20241004133703 ACCESSION NUMBER: 0002040125-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241004 DATE AS OF CHANGE: 20241004 EFFECTIVENESS DATE: 20241004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CellVax Therapeutics, Inc. CENTRAL INDEX KEY: 0002040125 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-525918 FILM NUMBER: 241354295 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE 3RD FLOOR, SUITE 130 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 2159415916 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE 3RD FLOOR, SUITE 130 CITY: MIAMI STATE: FL ZIP: 33136 D 1 primary_doc.xml X0708 D LIVE 0002040125 CellVax Therapeutics, Inc. 1951 NW 7TH AVENUE 3RD FLOOR, SUITE 130 MIAMI FL FLORIDA 33136 2159415916 DELAWARE None None Corporation true 2020 Fernando Kreutz c/o CellVax Therapeutics, Inc. 1951 NW 7th Avenue 3rd Floor, Suite 130 Miami FL FLORIDA 33136 Executive Officer Director Alberto da Costa Stein c/o CellVax Therapeutics, Inc. 1951 NW 7th Avenue 3rd Floor, Suite 130 Miami FL FLORIDA 33136 Director Other Decline to Disclose 06b false 2024-09-19 false true false 0 4999997 2084999 2914998 false 1 0 0 0 false CellVax Therapeutics, Inc. /s/ Fernando Kreutz Fernando Kreutz Chief Executive Officer 2024-10-04